Literature DB >> 7055095

The diagnostic value of flow cytometric DNA measurements in selected disorders of the human thyroid.

J V Johannessen, M Sobrinho-Simões, T Lindmo, K O Tangen.   

Abstract

A flow cytometric (FCM) analysis of biopsies from 19 patients with thyroid lesions (Hashimoto's thyroiditis, hyperplastic goiter, colloid and adenomatous nodular goiter, follicular adenoma, follicular carcinoma, anaplastic carcinoma) was performed to evaluate the relevance of such results for the individual diagnosis and prognosis and prognosis of such diseases. All cases of Hashimoto's thyroiditis, the colloid nodular goiters, and the hyperplastic goiter had a unimodal diploid pattern, while the anaplastic carcinomas were aneuploid. These lesions are, however, easily diagnosed on morphological grounds and their FCM classification would only be redundant. Follicular adenomas and follicular carcinomas may be either unimodal diploid or aneuploid, and our single case of adenomatous colloid goiter showed a bimodal DNA distribution. This means that a diploid modal DNA content in a follicular tumor does not rule out malignancy, while aneuploidy is not an unequivocal sign on malignancy. The evaluation of the percentage of cells in S-phase did not seem to contribute valuable information for the individual diagnosis of malignancy within the group of thyroid lesions studied. Our study indicates a rather limited clinical value of FCM measurements of DNA in the individual case of thyroid disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7055095     DOI: 10.1093/ajcp/77.1.20

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  22 in total

Review 1.  Diagnostic criteria in well-differentiated thyroid carcinomas.

Authors:  Elsa Fonseca; Paula Soares; Manuel Cardoso-Oliveira; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

Review 2.  The utility of some modern techniques in understanding thyroid pathology.

Authors:  Virginia A LiVoisi
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

3.  The adrenal cortex in ectopic adrenocorticotropic hormone syndrome: A morphological study with histology, transmission and scanning electron microscopy, flow cytometry, and image analysis.

Authors:  Kwok H Li; Sylvia L Asa; Kalman Kovacs; David Murray; William Singer
Journal:  Endocr Pathol       Date:  1990-09       Impact factor: 3.943

Review 4.  The study of endocrine tumors by flow and image cytometry.

Authors:  Ingrid Zbieranowski; David Murray
Journal:  Endocr Pathol       Date:  1992-06       Impact factor: 3.943

5.  Nucleic acid cytometry of homosexual-associated lymphoproliferative disease.

Authors:  J R Srigley; J J Butler; B M Osborne; L Guarda; B Barlogie
Journal:  Am J Pathol       Date:  1986-06       Impact factor: 4.307

6.  Reproducibility of flow cytometric assessment of follicular tumours of the thyroid.

Authors:  T P van Thiel; J C van der Linden; J P Baak; M M van de Sandt; C van Galen; P D Bezemer
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

7.  DNA aneuploidy in follicular adenomas of the thyroid gland.

Authors:  H Joensuu; P Klemi; E Eerola
Journal:  Am J Pathol       Date:  1986-09       Impact factor: 4.307

8.  Evaluation of the PAX8/PPARG translocation in follicular thyroid cancer with a 4-color reverse-transcription PCR assay and automated high-resolution fragment analysis.

Authors:  Alicia Algeciras-Schimnich; Dragana Milosevic; Bryan McIver; Heather Flynn; Honey V Reddi; Norman L Eberhardt; Stefan K G Grebe
Journal:  Clin Chem       Date:  2010-01-07       Impact factor: 8.327

9.  18F-fluorodeoxyglucose imaging in preoperative diagnosis of thyroid malignancy.

Authors:  H Joensuu; A Ahonen; P J Klemi
Journal:  Eur J Nucl Med       Date:  1988

10.  Diagnostic and prognostic utility of flow cytometric DNA measurements in follicular thyroid tumors.

Authors:  C S Grant; I D Hay; J J Ryan; E J Bergstralh; L M Rainwater; J R Goellner
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.